| 000 | 02281nam a2200409 i 4500 | ||
|---|---|---|---|
| 001 | on1001281899 | ||
| 003 | OCoLC | ||
| 005 | 20170911111918.0 | ||
| 007 | he bmb024bbca | ||
| 008 | 170816s2016 dcu bb f000 0 eng c | ||
| 040 |
_aGPO _beng _erda _cGPO _dMvI |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 050 | 1 | 4 |
_aKF27 _b.E5546 2016b |
| 074 | _a1019-B-01 (MF) | ||
| 088 | _aSerial no. 114-173 (United States. Congress. House. Committee on Energy and Commerce) | ||
| 086 | 0 | _aY 4.C 73/8:114-173 | |
| 099 | _aY 4.C 73/8:114-173 | ||
| 110 | 1 |
_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce. _bSubcommittee on Oversight and Investigations, _eauthor. |
|
| 245 | 1 | 0 |
_aBioresearch labs and inactivation of dangerous pathogens : _bhearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, September 27, 2016. |
| 264 | 1 |
_aWashington : _bU.S. Government Publishing Office, _c2016. |
|
| 300 |
_aiii, 99 pages ; _c24 cm |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_amicroform _bh _2rdamedia |
||
| 338 |
_amicrofiche _bhe _2rdacarrier |
||
| 500 | _aShipping list no.: 2017-0052-M. | ||
| 500 | _aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office. | ||
| 504 | _aIncludes bibliographical references. | ||
| 500 | _a"Serial no. 114-173." | ||
| 500 | _aCRDP Program record. | ||
| 533 |
_aMicrofiche. _b[Washington, D.C.] : _cU.S. Government Printing Office, _d[2017] _e2 microfiches : negative. |
||
| 650 | 0 |
_aPathogenic microorganisms _xHandling _zUnited States _xSafety measures. |
|
| 650 | 0 |
_aMicrobial inactivation _xSafety measures. |
|
| 650 | 0 |
_aBiological laboratories _zUnited States _xSafety measures. |
|
| 655 | 7 |
_aLegislative hearings. _2lcgft |
|
| 776 | 0 | 8 |
_iPrint version: _aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. _tBioresearch labs and inactivation of dangerous pathogens _w(DLC) 2017392623 _w(OCoLC)972479166 |
| 776 | 0 | 8 |
_iOnline version: _aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. _tBioresearch labs and inactivation of dangerous pathogens _w(OCoLC)968934049 |
| 999 |
_c266409 _d266409 |
||